- Home
- KMI vs SNN Comparison
KMI vs SNN Comparison
Compare KMI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMI
- SNN
- Stock Information
- Founded
- KMI 1936
- SNN 1856
- Country
- KMI United States
- SNN United Kingdom
- Employees
- KMI N/A
- SNN N/A
- Industry
- KMI Natural Gas Distribution
- SNN Industrial Specialties
- Sector
- KMI Utilities
- SNN Health Care
- Exchange
- KMI Nasdaq
- SNN Nasdaq
- Market Cap
- KMI 62.2B
- SNN 12.6B
- IPO Year
- KMI 2011
- SNN 1999
- Fundamental
- Price
- KMI $28.41
- SNN $30.28
- Analyst Decision
- KMI Buy
- SNN Hold
- Analyst Count
- KMI 16
- SNN 3
- Target Price
- KMI $28.25
- SNN $27.50
- AVG Volume (30 Days)
- KMI 13.0M
- SNN 905.6K
- Earning Date
- KMI 07-16-2025
- SNN 07-31-2025
- Dividend Yield
- KMI 4.12%
- SNN 2.38%
- EPS Growth
- KMI 5.43
- SNN 56.15
- EPS
- KMI 1.16
- SNN 0.47
- Revenue
- KMI $15,499,000,000.00
- SNN $5,810,000,000.00
- Revenue This Year
- KMI $9.70
- SNN $6.87
- Revenue Next Year
- KMI $4.74
- SNN $5.19
- P/E Ratio
- KMI $24.56
- SNN $32.11
- Revenue Growth
- KMI 1.38
- SNN 4.70
- 52 Week Low
- KMI $19.68
- SNN $23.69
- 52 Week High
- KMI $31.48
- SNN $31.72
- Technical
- Relative Strength Index (RSI)
- KMI 53.44
- SNN 59.79
- Support Level
- KMI $27.88
- SNN $29.99
- Resistance Level
- KMI $29.58
- SNN $30.77
- Average True Range (ATR)
- KMI 0.63
- SNN 0.40
- MACD
- KMI 0.03
- SNN 0.04
- Stochastic Oscillator
- KMI 49.13
- SNN 78.48
About KMI Kinder Morgan Inc.
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 80,000 miles of gas, refined products, and carbon dioxide pipelines. The company also owns one of the largest portfolios of gas and refined products storage and terminals. Most of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.